Exploring Partnership Governance in Global Health Proceedings of a Workshop (2018) / Chapter Skim
Currently Skimming:
Appendix C: Speaker and Moderator Biographical Sketches
Appendix C: Speaker and Moderator Biographical Sketches
Pages 85-98
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 85... ...
Dr. Boufford was awarded a Robert Wood Johnson Health Policy Fellowship at the Institute of Medicine in Washington, DC, for 1979–1980.
|
From page 86... ...
and subsequently named that body's liaison to the Centers for Disease Control and Prevention/Health Resources and Services Administration Advisory Committee. In 2014, he was appointed to be Director of the White House Office of National AIDS Policy.
|
From page 87... ...
He currently is a member of the Council on Foreign Relations, serves on the boards of InterAction and Challenge Seattle, and sits on several advisory groups, including as a trustee of the World Economic Forum's Global Health Challenge, on the stakeholder advisory panel for the global insurance and asset management firm AXA, and on the advisory board for Medtronics Labs.
|
From page 88... ...
A few of his accomplishments to date include large aircraft fleet acquisition and integration projects; development of new services built through focusing on strategic mergers and acquisition activities; new service ideas and innovation for the pharmaceutical, medical device, and health products supply chain and security; and new ways of thinking about corporate social responsibility.
|
From page 89... ...
Department of Health and Human Services Secretary appointment to the National Institute for Occupational Safety and Health Advisory Board and was a member of the Virginia Governor's Task Force on Health reform and cochair of the Insurance Reform Task Force. He is the past chair of Virginia Health Care Foundation and of the Board of City Lights Charter School in ashington, DC.
|
From page 90... ...
from McGill University and is pursuing a master's in Science in International Management from Lancaster University, United Kingdom. Kenneth Miller, J.D., is Associate General Counsel at the Bill & Melinda Gates Foundation, where he provides legal advice to the foundation's Global Health Division to help structure and negotiate agreements for innovative charitable investments, including grants, contracts, and p rogram-related investments to develop and deliver vaccines, drugs, and diagnostics to people most in need.
|
From page 91... ...
During the Clinton administration, Mr. Monahan served as Director of Intergovernmental Affairs at HHS, where he represented the department in negotiations with governors and state officials regarding scores of Medicaid and welfare demonstration waivers; and as Principal Deputy Assistant Secretary for Children and Families, in which he was responsible for assisting in implementation of federal welfare reform.
|
From page 92... ...
She also has significant expertise in advising global nongovernmental organizations (NGOs) on matters particular to their overseas operations, including establishing
|
From page 93... ...
She is a member of the Devex Strategic Advisory Council, working across sectors to encourage stronger partnership practices, and was a founding member of the INGO collective within FSG's Shared Value Initiative. She has spoken on the development, role, and management of partnerships for impact at USAID, FSG, Devex, SOCAP (Social Capital Markets)
|
From page 94... ...
He is a founding Co-Chair of the board of the Private-Sector Health Alliance in Nigeria and serves on Merck's Advisory Board for Merck for Mothers, Harvard's Defeating Malaria Initiative, the FHI 360 Advisory Board, and the World Economic Forum Global Agenda Council on Demographic Dynamics. He received the Geneva Health Forum Award in 2014 and the Harvard Health Leadership Award in 2012.
|
From page 95... ...
She drives significant cross-functional initiatives to enhance patient access to medicines, including supporting Pfizer's engagement in Access Accelerated, a multicompany initiative to address the full spectrum of access barriers to medicines for noncommunicable diseases (NCDs) in lower-income countries, and providing policy support for innovative financing and reimbursement approaches.
|
From page 96... ...
While at Merck & Co., Inc., he was a leader of the company's global HIV/AIDS policy for more than a decade and was centrally involved in the UN/Industry Accelerating Access Initiative established in 2000 to help improve HIV/ AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005–2009)
|
From page 97... ...
Wirtz, M.Sc., Ph.D., is an Associate Professor in the Department of Global Health at the Boston University School of Public Health, where she is also Director of the World Health Organization Collaborating Center in Pharmaceutical Policy. Her research interests include the role of the private sector to promote equitable access and efficient use of medicines in low- and middle-income countries, medicines price analysis, generic medicines policies, and access to medicines for noncommunicable diseases.
|
From page 98... ...
In this position, he oversaw grants totaling more than $9 billion in programs directed at applying technologies to address major health challenges of the developing world including tuberculosis, HIV, malaria and other infectious diseases, malnutrition, and maternal and child health. He was formerly Chairman, Research and Development and a Member of the Board of Directors of G laxoSmithKline and before that was Chair of the Department of Internal Medicine and Physician-in-Chief at the University of Michigan Medical Center.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.